Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/8592
Full metadata record
DC FieldValueLanguage
dc.rights.licenseBY-NC-ND-
dc.contributor.authorPavlovic, Mladen-
dc.contributor.authorJovanovic I.-
dc.contributor.authorArsenijevic, Nebojsa-
dc.date.accessioned2020-09-19T16:10:20Z-
dc.date.available2020-09-19T16:10:20Z-
dc.date.issued2018-
dc.identifier.issn1820-8665-
dc.identifier.urihttps://scidar.kg.ac.rs/handle/123456789/8592-
dc.description.abstract© 2017 Mladen Pavlovic et al., published by De Gruyter Open 2017. Cytokines are small pleiotropic polypeptids secreted dominantly by the cells of the immune system. These polypeptids are main mediators of innate and acquired immunity, responsible for clonal expansion and differentiation of immune cells, initiation of immune response and enhancing of effector functions of leukocytes. Cytokine-related effects are most studied in the fields of inflammation, immunology, and cancer biology. In this review we discuss one of the most intriguing, recently discovered proinflammatory cytokine, interleukin 32.-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceSerbian Journal of Experimental and Clinical Research-
dc.titleInterleukin-32 in Infection, Inflammation and Cancer Biology-
dc.identifier.doi10.1515/sjecr-2016-0085-
dc.identifier.scopus2-s2.0-85042712749-
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

116

Downloads(s)

9

Files in This Item:
File Description SizeFormat 
10.1515-sjecr-2016-0085.pdf258.27 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons